Geron CorporationGERNNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating
Buy
20 analysts·High coverage
85%
Rating Distribution
Strong Buy
00%
Buy
1785%
Hold
315%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 279% higher.

Bear Case
$4.00
+157%
Consensus
$5.89
+279%
Bull Case
$8.00
+414%
Price Range20 analysts
Low
Consensus
High
$4.00
$8.00
Current Target
Current Price
$1.55
Upside to Target
$4.33

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 27, 2025Barclays
Geron price target lowered to $4 from $9 at Barclays
Target:$4.00
+148.4%from $1.61
Nov 5, 2024H.C. Wainwright
H.C. Wainwright Starts Geron Corporation (GERN) at Buy
Target:$8.00
+88.7%from $4.24
Oct 22, 2024B.Riley Financial
B.Riley Reiterates Buy Rating on Geron Corporation (GERN) ahead of Q3
Target:$5.50
+39.2%from $3.95
Sep 9, 2024Leerink Partners
Geron initiated with an Outperform at Leerink
Target:$7.00
+64.7%from $4.25
Jun 10, 2024Goldman Sachs
Geron Corporation (GERN) PT Raised to $6 at Goldman Sachs
Target:$6.00
+21.3%from $4.95
Jun 10, 2024Stifel Nicolaus
Geron price target raised to $7 from $6 at Stifel
Target:$7.00
+52.5%from $4.59
Apr 30, 2024Robert W. Baird
Baird Downgrades Geron Corporation (GERN) to Neutral 'on Valuation Concerns'
Target:$4.50
+8.7%from $4.14
Mar 15, 2024Needham
Geron Corporation (GERN) PT Raised to $5 at Needham, 'anticipate imetelstat will receive the go-ahead on or prior to its June 16 PDUFA date'
Target:$5.00
+48.8%from $3.36
Mar 15, 2024Goldman Sachs
Geron Corporation (GERN) PT Raised to $5 at Goldman Sachs
Target:$5.00
+48.8%from $3.36
Jan 9, 2023Needham
Needham Maintains Buy on Geron, Raises Price Target to $4
Target:$4.00
+43.6%from $2.79
Jan 4, 2023Wedbush
Wedbush Maintains Outperform on Geron, Raises Price Target to $6
Target:$6.00
+90.5%from $3.15